← FDA DRUG APPROVALS

FDA ANDA · ANDA074955

KETOROLAC TROMETHAMINE

Sponsor: WATSON LABS

APPLICATION
ANDA074955
TYPE
ANDA
ORIGINAL APPROVAL
1997-09-19
LATEST ACTION
2019-10-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

KETOROLAC TROMETHAMINEDiscontinued
KETOROLAC TROMETHAMINE 10MG · TABLET · ORAL

Approval history

2019-10-18Labeling · Supplement 4 · standardAP
2016-05-09Labeling · Supplement 3 · standardAP
1998-07-16Manufacturing (CMC) · Supplement 1AP
1997-09-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →